ICB, short for International Classification of Biotechnology, refers to a standardized system of categorizing and organizing information related to biotechnology. It is an internationally recognized classification system that aims to facilitate the collection and dissemination of statistical data on biotechnology research and development activities.
The ICB provides a comprehensive and hierarchical structure, consisting of various classes, subclasses, and groups, to classify and group biotechnology-related information. It covers a wide range of areas within the field, including research, development, production, and application of biotechnological techniques and products.
By utilizing the ICB, researchers, experts, and organizations can effectively communicate, share, and analyze biotechnology-related information across various domains and sectors. The system enhances the accessibility, comparability, and accuracy of data related to biotechnology, thus supporting decision-making processes, policy formulation, and the advancement of research and development in the field.
ICB plays a significant role in monitoring and assessing the impact and progression of biotechnology worldwide. It enables countries to monitor trends and developments in biotechnology, identify strengths and weaknesses, and determine areas of focus for potential collaboration and investment.
Overall, the International Classification of Biotechnology (ICB) offers a standardized framework for the organization and analysis of biotechnology-related data, contributing to the advancement and understanding of the field on both national and global scales.
